Breaking Down Luminar Technologies Inc.’s Q3 2024 Earnings Call: A Quirky and Informative Recap Description Luminar Technologies, Inc. (NASDAQ: LAZR) recently held its Q3 2024 Earnings Call on November 11, 2024, at 5:00 PM ET. The call included key representatives such as Yarden Amsalem, Senior Manager of Investor Relations; Austin Russell, Founder and CEO; and…
A Class Action Lawsuit Against Applied Therapeutics, Inc. New York, NY / Access Newswire / January 24, 2025 Pomerantz LLP has announced that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT). Investors who have potentially been affected by this case are advised to contact Danielle Peyton…
Is the Bitcoin ETF Craze Fizzling Out? What Happened? It seems like just yesterday that everyone was rushing to invest in Bitcoin ETFs, but the tide may be turning. On January 23, inflows into Bitcoin ETFs in the United States hit a steep decline, dropping to $188.65 million from over $1 billion earlier in the…
UBS Group AG: A Mixed Bag of Results and Market Reactions UBS Group AG, the Swiss global financial services company, experienced a tumultuous trading session on Tuesday, despite announcing a new buyback program worth up to US$3 billion. The news failed to overshadow the underwhelming profit figures reported by the bank. Underperforming Profits UBS Group…
Levi & Korsinsky Investigates Cardlytics, Inc. What’s Going On? It seems like there’s some commotion over at Cardlytics, Inc. Investors have caught wind of a potential investigation into the company regarding possible violations of federal securities laws. Talk about drama! The Numbers Game According to reports, Cardlytics recently shared their financial results for the second…
The Impact of Marqeta, Inc. Investment Losses New York, NY / Access Newswire / January 24, 2025 If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, consider contacting Joseph E. Levi, Esq. Investing in the stock market can be a…
Nektar Therapeutics Announces Positive Data from Phase 1b Studies in Inflammatory Skin Conditions Overview Data from multiple Phase 1b studies in inflammatory skin conditions demonstrate durable dose-dependent improvements in physician-assessed disease activity and patient-reported outcomes. Biomarker analyses show a plurality of Treg-mediated pathways with potential effects on tissue resident memory T cell populations, resulting in…
Donald Trump’s Controversial Statement Sparks Debate The Most “Important” and “Dangerous” Statement of the Election Cycle? During a recent rally in South Carolina, Donald Trump made a statement that has sent shockwaves through the political landscape. According to one democracy expert, Trump’s remarks could have far-reaching consequences for both the United States and its allies….
